SIAL Paris 2024 is on! Request Your Tickets
Business Wire India SIAL Paris, to be held from 19 to 23 October at Paris Nord Villepinte, is the world’s largest food trade show, with over 285,000 visitors, 7,500 exhibitors…
Business Wire India SIAL Paris, to be held from 19 to 23 October at Paris Nord Villepinte, is the world’s largest food trade show, with over 285,000 visitors, 7,500 exhibitors…
Business Wire India Driver and Vehicle Licencing Agency (DVLA) and Thales cut carbon footprint of UK driving licence as well as tachograph and residence cards, by over one third in…
Business Wire India Sisvel, operator of the leading cellular IoT patent pool, has launched a new informational campaign that will help IoT device makers navigate the legal issues involved in…
Business Wire India Plasser India, a subsidiary of Plasser & Theurer group from Austria, renowned globally for designing and manufacturing state-of-the-art machines for track maintenance, track laying, and track renewal,…
Business Wire India Contract to design a 10MW pressurised solid oxide electrolyser (“SOEC”) module to produce green hydrogen at 36kWh/kg Builds on the data being generated from the existing demonstration…
Business Wire India OmniAb, Inc. (NASDAQ: OABI) todayannounced the publication of a peer-reviewed paper titled “Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies” in the Journal…
Business Wire India LambdaTest, a leading cloud-based unified testing platform, introduces its latest offering, Test Manager. With seamless integration of test triggering, reporting, and organization, Test Manager promises to streamline…
Business Wire India Cyble, the leading provider of AI-driven cybersecurity solutions, has appointed Steve Ingram to its advisory board. Ingram will play an important role in advancing Cyble’s vision and…
Business Wire India RevBits today announced that it was recognized as a winner in the Privileged Access Management and Endpoint Security categories by the 2024 Cybersecurity Excellence Awards®. The review…
Business Wire India Potential best-in-class ATR inhibitor tuvusertib being explored in Phase II combination clinical studies; recently licensed PARP1 inhibitor M9466 to be evaluated in Phase Ib combination dose-finding studies…